TRIAL - EMBASE on Ovid
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community. It allows users to successfully perform critical functions such as pharmacovigilance, as well as generating high-quality systematic reviews in support of evidence-based medicine and drug and medical device efficacy studies.
The trial is active between the 2nd July and the 25th July 2019 and can be accessed .
If you experience any problems filling in/submitting the survey form or accessing Embase on OVID, fill in the Electronic Resources Access Problems form and we will investigate and get back to you as soon as possible.
听